Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05009238
Other study ID # p.T.RCE/012/003190
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date April 2023

Study information

Verified date August 2022
Source Cairo University
Contact Hend Hamdy, PHD
Phone 01024420121
Email hendhamdy110@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Menopause is a natural process in women's life with hormonal fluctuations that cause physical and emotional symptoms such as(Hot flashes, insomnia, physical in activity, unstable mood, difficulties in memory and concentration, anxiety, stress, irritability, unstable body mass, sexual dysfunction, feelings of sadness, infertility, and depression). Balance disturbances are common in the community as a whole and increase in frequency with age. The risk of falling increases from age 45 in women and peaks in the 55-59-year age group. Around the time of the menopause, estrogen production decreases dramatically and bone loss accelerates, which predisposes for fractures if a fall occurs.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date April 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers No
Gender Female
Age group 45 Years to 59 Years
Eligibility Inclusion Criteria: - Post-menopausal women: Their age will be ranged between 45-59 years old, with low back pain. Exclusion Criteria: - Infection disease or fever. - Foot ulcers. - Foot infection or undergoing foot surgery. - Recent fracture in foot and toes with unhealed wounds. - Thrombotic disease of lower extremities. - Deep proprioception loss. - Peripheral neuropathy. - Gout or advanced arthritis affecting the foot and toes.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
lumbar stabilization exercises
selected exercises will taught to participant and practiced 3 times per week for 6 weeks

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hend Hamdy

Outcome

Type Measure Description Time frame Safety issue
Primary Step length the distance between the point of initial contact of one foot and the point of initial contact of the opposite foot measured by cm about 6 weeks.
Primary step symmetry right to left time distribution measured by second about 6 weeks.
Primary walking speed the ratio of distance to the time in which the distance was covered by the subject measured by m/s about 6 weeks.
See also
  Status Clinical Trial Phase
Completed NCT02235051 - Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors N/A
Completed NCT01635413 - Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial) N/A
Completed NCT00701337 - Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route Phase 4
Recruiting NCT04705623 - Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women N/A
Withdrawn NCT03238703 - Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Phase 4
Completed NCT03756272 - Stellate Ganglion Block to Reduce Hot Flushes N/A
Recruiting NCT03953157 - Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors N/A
Completed NCT00338728 - Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer Phase 2
Completed NCT01482702 - Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors N/A
Terminated NCT01842217 - Validation of [18F]FES for Imaging of Brain Estrogen Receptors N/A
Completed NCT01172574 - Motor Control Exercise in Osteoporotic Women N/A
Completed NCT00530582 - Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women Phase 4
Completed NCT01825785 - A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) Phase 1
Completed NCT04364061 - Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE) N/A
Completed NCT03180294 - Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer Phase 2
Recruiting NCT06445842 - Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women N/A
Completed NCT01753908 - Broccoli Sprout Extract in Treating Patients With Breast Cancer Early Phase 1
Not yet recruiting NCT06377631 - Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity N/A
Recruiting NCT06228768 - Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer N/A
Terminated NCT01294397 - Effects of Denosumab on the Pharmacokinetics of Etanercept Phase 1